To start testing this hypothesis, we determined whether the PRKD1 gene can be reexpressed in invasive breast cancer and if this could reverse the invasive phenotype in vitro as well as in vivo (Figures 3,4,5, and6). This evidence concerns the gene PRKD1 and invasive breast carcinoma.